-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
November 19, 2009 - considering
improvements in accuracy, as well as potential shifts in the disease spectrum for positive
diagnoses … For example, in colon cancer diagnosis, both capsule endoscopy (index test)
and colonoscopy (reference … not necessarily undesirable as long as there are no
changes in the disease spectrum for the positive diagnoses … Home diagnosis of obstructive sleep
apnea-hypopnea syndrome. … Diagnostic test accuracy may vary with
prevalence: implications for evidence-
based diagnosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
July 01, 2010 - Survival rates depend on the
stage of disease at diagnosis. … In other words, these studies are
not intended to provide a final diagnosis as to the nature of the … The study must have enrolled patients referred for the purpose of primary
diagnosis of a breast abnormality … Keywords included in the search
strategy encompass the concepts of breast cancer, diagnosis, noninvasive … However, women who experience a false-
negative error may die as the result of a delayed cancer diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
April 03, 2014 - Additionally, the diagnosis
requires that symptoms not be better explained by other sleep disorders … For treatments to be effective, an accurate diagnosis must first be made. … Study inclusion criteria
Category Criteria for Inclusion
Study • adults with diagnoses consistent … of adults:
older adults
adultswith insomnia disorder and coexisting medical or mental health diagnoses … Clinical diagnosis and
misdiagnosis of sleep disorders.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
September 20, 2013 - Practice Center Systematic Review Protocol
Project Title: Core Needle and Open Surgical Biopsy
for Diagnosis … develop breast cancer during their lifetime, and an
estimated 2.7 million women had a current or past diagnosis … The process of
breast cancer diagnosis is initiated by detection of an abnormality through self-examination … test performance of
different types of core-needle breast biopsy when compared with open biopsy for diagnosis … illustrates how core-needle biopsy versus open surgical biopsy may result in KQ 1 outcomes
such as diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
September 06, 2016 - For example, in 2012, asthma was one of the top
twenty leading diagnosis groups for primary care visits … However, the diagnosis remains clinical; there is no single
gold standard diagnostic test. … The guidelines address the diagnosis, evaluation, and treatment of
asthma. … Specifically,
1.a: What is the diagnostic accuracy of FeNO measurement(s) for making the
diagnosis … Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis
and management of asthma.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_surveillance.pdf
September 01, 2012 - all/consecutive patients
or not, whether the study was
prospective in design or not,
whether all diagnoses … differences; whether the studies
blinded image readers to clinical
information or not; whether all
diagnoses … AND
sensitivity and specificity"/ or early diagnosis/ or diagnostic imaging/ or diagnostic value/ or … all/consecutive patients or not,
whether the study was prospective in design
or not, whether all diagnoses … differences;
whether the studies blinded image readers
to clinical information or not; whether all
diagnoses
-
effectivehealthcare.ahrq.gov/products/form/hyperactivity-disorder/draft-comments
-
effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research-protocol
-
effectivehealthcare.ahrq.gov/products/bladder-cancer-non-muscle-invasive/research
-
effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-antigen-3-gene/research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-protocol.pdf
July 10, 2018 - vocational, education); return to school/work; prevention or reduction of
comorbid psychiatric or medical diagnoses … (DSM-III, DSM-IV, or
DSM-5)
Children (<18 years old)
Diagnosis of acute stress disorder
Studies … Census categories)*
l. % with PTSD diagnosis
m. … Comorbid diagnoses required for study entry
n. % Treatment naïve*
o. % with depression*
p. % with … Proportion who achieved PTSD diagnostic change (loss of diagnosis), by condition
l.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-protocol.pdf
July 10, 2018 - vocational, education); return to school/work; prevention or reduction of
comorbid psychiatric or medical diagnoses … (DSM-III, DSM-IV, or
DSM-5)
Children (<18 years old)
Diagnosis of acute stress disorder
Studies … Census categories)*
l. % with PTSD diagnosis
m. … Comorbid diagnoses required for study entry
n. % Treatment naïve*
o. % with depression*
p. % with … Proportion who achieved PTSD diagnostic change (loss of diagnosis), by condition
l.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
January 01, 2010 - testing or subsequent management options
associated with use of the PCA3 assay for prostate cancer diagnosis … for social, economic, or psychological harm associated with use of
PCA3 assay for prostate cancer diagnosis … critical need for an understanding of how this
marker compares to current practices for screening, diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
July 01, 2012 - CER # 19:
Comparative Effectiveness of Core Needle Biopsy and Open
Surgical Biopsy for Diagnosis of … One expert felt
this is only true for
women who have a
benign diagnosis. … Intraductal papillomas
of the breast: Diagnosis and management of
151 patients. … underestimation rate,
difference by guidance or
needle type not statisically
significant ND
40% of LCIS diagnoses … upgraded, 27% of ALH
diagnoses upgraded -
difference not statisically
significant ND
Londero,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
April 01, 2013 - was
2.8 years.1,4
Screening and Diagnosis
There are two separate populations
for which screening … The procedure-related mortality was
0.055 percent.5
RHC not only confirms the diagnosis of PAH but … Guidelines on diagnosis
and treatment of pulmonary arterial hypertension. … Diagnosis and differential
assessment of pulmonary arterial hypertension. … Guidelines for the
diagnosis and treatment of pulmonary hypertension: the Task
Force for the Diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
May 29, 2025 - computed tomography (CT), or ultrasound
Comparator(s): No use of imaging
Outcome(s): Accuracy of diagnosis … What is the comparative safety and effectiveness of imaging to that of no
imaging in the diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-child-adolesc-mental-health-grand-rounds.pptx
May 22, 2025 - Michelle Zabel, M.S.S.
3:35–3:50 Presentation of Diagnosis and Management of Obsessive Compulsive Disorders … ADHD Diagnosis and Treatment in Children and Adolescents
Southern California Evidence-based Practice … Lauren Pilcher, Robyn Wheatley
9
Eligibility Criteria for Studies Reporting on clinical ADHD
Diagnosis … when tool discriminates ADHD from typically developing youth
Tools tend to generate false positive diagnoses … in youth who have diagnoses other than ADHD
AUC
Specificity
Sensitivity
15
KQ1
Diagnosis Conclusions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0311_06-17-2008.pdf
January 01, 2008 - renal function impairment
Intervention(s): Measurement of troponin levels
Comparator(s): Clinical diagnosis … disease, a
systematic review on this topic would have a significant impact by aiding clinicians in the diagnosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
January 01, 2011 - treprostinil and ambrisentan); combination
therapies; use of testing (vasoreactivity, biomarkers) for diagnosis … What are the optimal testing strategies and modalities (vasoreactivity, biomarker)
for guiding the diagnosis